DPP3 and neuroblastoma: It has been reported that overexpression of DPP3 could potently activate the ARE in neuroblastoma cells (IMR-32 cells), leading to increased expression levels of NAD(P)H:quinone oxidoreductase 1 (NQO1), a phase II detoxifying enzyme regulated by ARE.